JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

JNJ

234.06

+1.52%↑

ISRG

480.04

-3.61%↓

ABT

108.67

-0.8%↓

RDY

13.84

+2.29%↑

NEOG

10.34

+1.27%↑

Search

Envista Holdings Corp

Închisă

SectorSănătate

22.9 -1.55

Rezumat

Modificarea prețului

24h

Curent

Minim

22.73

Maxim

23.66

Indicatori cheie

By Trading Economics

Venit

-57M

-30M

Vânzări

-12M

670M

P/E

Medie Sector

267.222

90.422

EPS

0.32

Marjă de profit

-4.523

Angajați

12,300

EBITDA

18M

97M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+4.69% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

613M

4B

Deschiderea anterioară

24.45

Închiderea anterioară

22.9

Sentimentul știrilor

By Acuity

50%

50%

147 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bullish Evidence

Envista Holdings Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

2 feb. 2026, 23:52 UTC

Achiziții, Fuziuni, Preluări

Elliott Management Doesn't Plan to Tender Its Shares at the Current Terms

2 feb. 2026, 23:52 UTC

Achiziții, Fuziuni, Preluări

Elliott Management: Toyota Fudosan Revised Tender Offer for Toyota Industries 'Very Significantly Undervalues' Company

2 feb. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Signs of U.S. Economic Strength -- Market Talk

2 feb. 2026, 23:38 UTC

Market Talk

Gold Rises on Likely Technical Recovery, Dip-Buying Interest -- Market Talk

2 feb. 2026, 23:28 UTC

Market Talk

SpaceX, xAI Deal Further Consolidates Musk's Businesses -- Market Talk

2 feb. 2026, 23:23 UTC

Câștiguri

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- 2nd Update

2 feb. 2026, 22:57 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 22:22 UTC

Achiziții, Fuziuni, Preluări

What the Blockbuster SpaceX--xAI Merger Can Mean for Tesla Stock -- Barrons.com

2 feb. 2026, 22:08 UTC

Market Talk

Australian Inflation Woes Rooted In Excess Govt Spending -- Market Talk

2 feb. 2026, 21:51 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2 feb. 2026, 21:49 UTC

Câștiguri

Disney's Streaming Profit Surges as CEO Decision Approaches -- 5th Update

2 feb. 2026, 21:39 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 21:36 UTC

Câștiguri

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- Update

2 feb. 2026, 21:34 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 21:28 UTC

Achiziții, Fuziuni, Preluări

What a SpaceX--xAI Merger Could Mean for Tesla Stock -- Barrons.com

2 feb. 2026, 21:23 UTC

Câștiguri

BYD, Chinese EV Stock Plunge On Weak Data. What That Means for Tesla Stock. -- Barrons.com

2 feb. 2026, 21:19 UTC

Câștiguri

Palantir Technologies: U.S. Commercial Business Growing at 'Astonishing' Rate, Generating $507 Million Last Quarter, 137% Increase Over the Same Period the Year Before >PLTR

2 feb. 2026, 21:17 UTC

Câștiguri

Palantir Achieves Another Revenue Record With $1.41 Billion Quarter -- WSJ

2 feb. 2026, 21:17 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 21:10 UTC

Câștiguri

Palantir Reports Strong Earnings. The Stock Is Rising. -- Barrons.com

2 feb. 2026, 21:08 UTC

Câștiguri

Palantir Technologies: Rule of 40 Score Is Now 127% >PLTR

2 feb. 2026, 21:07 UTC

Câștiguri

Palantir Technologies: Sees 2026 U.S. Comml Rev in Excess of $3.144B, Representing Growth Rate of at Least 115% >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies 4Q Net $608.7M >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies 4Q Rev $1.41B >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies Sees 1Q Rev $1.53B-$1.54B >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies Sees FY Rev $7.18B-$7.2B >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies 4Q Adj EPS 25c >PLTR

2 feb. 2026, 21:05 UTC

Câștiguri

Palantir Technologies 4Q EPS 24c >PLTR

2 feb. 2026, 20:40 UTC

Market Talk

Treasury Yields, Dollar Rise Amid Signs of Resilient U.S. Economy -- Market Talk

Comparație

Modificare preț

Envista Holdings Corp Așteptări

Obiectiv de preț

By TipRanks

4.69% sus

Prognoză pe 12 luni

Medie 24.57 USD  4.69%

Maxim 28 USD

Minim 21 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEnvista Holdings Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

8 ratings

5

Cumpărare

3

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

15.98 / N/ASuport & Rezistență

Termen scurt

Strong Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

147 / 352 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
help-icon Live chat